Maccura Biotechnology Co.Ltd (SHE:300463)

Market Cap	6.52B -22.0%
Revenue (ttm)	2.21B -19.0%
Net Income	-117.46M
EPS	-0.19
Shares Out	604.67M
PE Ratio	n/a
Forward PE	23.98
Dividend	0.10 (0.96%)
Ex-Dividend Date	May 28, 2025

Volume	5,128,497
Average Volume	5,987,531
Open	10.92
Previous Close	10.79
Day's Range	10.65 - 11.06
52-Week Range	10.40 - 14.20
Beta	0.37
RSI	47.19
Earnings Date	Apr 29, 2026

About SHE:300463

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1994
• Employees: 3,106
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300463

Financial Performance

In 2024, SHE:300463's revenue was 2.55 billion, a decrease of -11.98% compared to the previous year's 2.90 billion. Earnings were 126.81 million, a decrease of -59.44%.